ArticleAbdominal radiology (New York)2024

Predicting the progression-free survival of gastrointestinal stromal tumors after imatinib therapy through multi-sequence magnetic resonance imaging.

Linsha Yang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.